L
LTP
LTR PHARMA LIMITED
0.415
-0.015-3.49%Closed16:10 04/10 AEST
OPEN/PREV CLOSE0.430/0.430
TODAY RANGE0.400-0.430
VOL171.51K
MARKET CAP75.44M
52 WEEK RANGE0.270-0.810
AVG VOL (3M)255.95K
% TURNOVER0.09%
TURNOVER70.62K
P/E (TTM)-8.4008
% RANGE6.98%
EPS(TTM)-0.0494
P/E(FORWARD)--
P/B2.806
BVPS0.148
DIVIDEND--
P/S35.78
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP43.72M
SHARES OUTSTANDING181.78M
NEXT EARNINGS--
FREE FLOAT105.35M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·03/10 21:42
Investor Presentation
ASX·03/04 21:33
SPONTAN Phase II Clinical Study Completes Recruitment
ASX·02/25 21:18
Appendix 4D and Half Yearly Report
ASX·02/10 01:22
Application for quotation of securities - LTP
ASX·02/01 21:48
SPONTAN Shows Positive Outcomes in Younger Men with ED
ASX·01/27 21:29
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·01/21 21:54
First Patients Dosed in SPONTAN Phase II Clinical Study
ASX·01/21 04:36
Application for quotation of securities - LTP
ASX·01/16 05:59
Notification regarding unquoted securities - LTP
ASX·01/12 21:24
Patient Recruitment Commences for SPONTAN Phase II Study
ASX·01/07 22:15
SPONTAN Phase 1 Study Accepted for WMSM 2026 Podium
ASX·12/22/2025 06:04
Notification regarding unquoted securities - LTP
ASX·12/16/2025 22:13
LTR Pharma Surpasses 1,000 SPONTAN Prescriptions
ASX·12/10/2025 22:46
Application for quotation of securities - LTP
ASX·12/09/2025 22:40
TGA Provides Regulatory Clearance for SPONTAN Phase II
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others